42. According to OBRA 90, which of the following patients must be offered a consultation with the pharmacist?

Answer: C

Explanation:

Patients receiving a new medication must be offered a consultation with the pharmacist according to OBRA 90.

Patients who are receiving a new medication are required to be offered a consultation with the pharmacist as per OBRA 90 regulations. This is to ensure that patients understand their medication, potential side effects, and any necessary precautions.

A) A patient updating their insurance information

This option is incorrect because merely updating insurance information does not involve a new medication or require consultation regarding medication management. OBRA 90 focuses on patient safety and education related to medications, which is not applicable in this scenario.

B) A patient dropping off a prescription

While a patient dropping off a prescription may lead to a consultation, it is not a requirement under OBRA 90 unless the prescription involves a new medication. Therefore, this option does not meet the criteria established by the regulation for mandatory consultation.

C) A patient receiving a new medication

This option is correct as OBRA 90 mandates that patients receiving a new medication must be offered a consultation with the pharmacist. This is crucial for ensuring that patients are informed about their medications, including usage and potential interactions.

D) A patient purchasing an over-the-counter medication

This option is incorrect since OBRA 90 specifically pertains to prescription medications and the consultations related to them. Over-the-counter medications do not fall under the same regulations, and thus a consultation is not a requirement in this case.

Conclusion

The requirement for consultation under OBRA 90 clearly applies to patients receiving a new medication, making option C the definitive correct choice. Other options, while related to pharmacy operations, do not align with the specific regulations governing patient consultations concerning medication safety and education.